Vcanbio Cell & Gene Engineering Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Hongqi Wang
Chief executive officer
CN¥419.3k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 7.5yrs |
| Board average tenure | 4.6yrs |
Recent management updates
Recent updates
Vcanbio Cell & Gene Engineering Corp., Ltd's (SHSE:600645) Popularity With Investors Is Under Threat From Overpricing
Sep 27
Does Vcanbio Cell & Gene Engineering (SHSE:600645) Have A Healthy Balance Sheet?
Aug 26Does Vcanbio Cell & Gene Engineering (SHSE:600645) Have A Healthy Balance Sheet?
May 24Vcanbio Cell & Gene Engineering's (SHSE:600645) Soft Earnings Are Actually Better Than They Appear
May 02Subdued Growth No Barrier To Vcanbio Cell & Gene Engineering Corp., Ltd's (SHSE:600645) Price
Apr 24CEO
Hongqi Wang (60 yo)
less than a year
Tenure
CN¥419,300
Compensation
Mr. Hongqi Wang is General Manager of Vcanbio Cell & Gene Engineering Corp. Ltd from January 15, 2024 and serves as its Vice Chairman since May 16, 2023. He serves as Non-Independent Director of BGI Genomi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & GM | less than a year | CN¥419.30k | no data | |
| Deputy GM & Director | no data | CN¥1.07m | no data | |
| Deputy GM & Director | 8.8yrs | CN¥1.06m | no data | |
| Deputy GM & Secretary | 6.1yrs | CN¥1.02m | no data | |
| Deputy GM and R&D Director | no data | CN¥2.42m | no data | |
| Deputy GM & CFO | less than a year | no data | no data | |
| Chief Technical Quality Officer | 10.8yrs | CN¥646.20k | no data | |
| Chief Human Resources Officer | 10.8yrs | CN¥618.30k | no data |
7.5yrs
Average Tenure
50yo
Average Age
Experienced Management: 600645's management team is seasoned and experienced (7.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & GM | 1.6yrs | CN¥419.30k | no data | |
| Deputy GM & Director | 6yrs | CN¥1.07m | no data | |
| Deputy GM & Director | 7.3yrs | CN¥1.06m | no data | |
| Vice Chairman | 15.5yrs | CN¥1.93m | 0.039% CN¥ 3.9m | |
| Chairman of the Board | 2.8yrs | no data | no data | |
| Independent Director | 4.6yrs | CN¥100.00k | no data | |
| Director | 6yrs | no data | no data | |
| Independent Director | 4.6yrs | CN¥100.00k | no data | |
| Chairman Supervisory Board | 1.6yrs | no data | no data |
4.6yrs
Average Tenure
56yo
Average Age
Experienced Board: 600645's board of directors are considered experienced (4.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 08:15 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vcanbio Cell & Gene Engineering Corp., Ltd is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bin Wu | Founder Securities Co., Ltd. |
| Ye Hui Yang | Huatai Research |
| Ban Wang | Minsheng Securities Co. |